Skip to main content
Livermore
Livermore
ZHEN

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
168,036
Value
$7.17M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BSX by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026168,036$7.17M<0.1%−372,027−68.9%ReducedHolders
Q1 2026540,063$33.9M0.1%−13,948−2.5%ReducedHolders
Q4 2025554,011$52.8M0.2%+8,343+1.5%AddedHolders
Q3 2025545,668$53.3M0.3%+55,582+11.3%AddedHolders
Q2 2025490,086$52.6M0.3%−62,405−11.3%ReducedHolders
Q1 2025552,491$55.4M0.3%+23,477+4.4%AddedHolders
Q4 2024529,014$47.3M0.3%−106,994−16.8%ReducedHolders
Q3 2024636,008$53.3M0.3%+158,978+33.3%AddedHolders
Q2 2024477,030$36.7M0.2%−11,122−2.3%ReducedHolders
Q1 2024488,152$33.4M0.2%−211,580−30.2%ReducedHolders
Q4 2023699,732$40.5M0.3%+627,703+871.5%AddedHolders
Q3 202372,029$3.80M<0.1%−16,624−18.8%ReducedHolders
Q2 202388,653$4.80M<0.1%−316,990−78.1%ReducedHolders
Q1 2023405,643$20.3M0.2%+212,591+110.1%AddedHolders
Q4 2022193,052$8.93M0.1%+70,415+57.4%AddedHolders
Q3 2022122,637$4.78M<0.1%−27,649−18.4%ReducedHolders
Q2 2022150,286$5.61M<0.1%−451,411−75.0%ReducedHolders
Q1 2022601,697$26.6M0.1%−1,157,739−65.8%ReducedHolders
Q4 20211,759,436$74.7M0.3%+1,000,868+131.9%AddedHolders
Q3 2021758,568$32.9M0.1%+336,101+79.6%AddedHolders
Q2 2021422,467$18.1M0.1%+305,432+261.0%AddedHolders
Q1 2021117,035$4.52M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.